LONGUEUIL, QC, Feb. 28, 2020 /CNW Telbec/ - Azimut Exploration Inc. ("Azimut" or the "Company") (TSXV: AZM) is very pleased to announce the appointment of Mr. Glenn Mullan as a Director of the Company. Mr. Mullan was elected on February 27, 2020, during the last Annual General Meeting of Shareholders held in Montreal.
Glenn Mullan has been the President, Chief Executive Officer and Chairman of Golden Valley Mines Ltd. since 2000. He is also a director of Abitibi Royalties Inc. (Executive Chairman) and several other natural resource issuers trading on the TSX Venture Exchange. As a geologist and prospector, Glenn Mullan played an instrumental role from the discovery to feasibility stages of the large Canadian Royalties Inc. nickel discoveries in Nunavik (Northern Quebec).
Mr. Mullan brings with him an in-depth knowledge of the global mining industry, including leading positions in mining organizations. He was President of the Prospectors and Developers Association of Canada (PDAC) from 2016 to 2019. He graduated from Concordia University with a Bachelor of Science in Geology (1992) and received an ICD.D designation from the Institute of Corporate Directors in Montreal (2007).
Other re-elected Azimut board members are Mr. Michel Brunet, Dr. Jean-Marc Lulin, Mrs. Angelina Mehta, Mr. Jean-Charles Potvin, Mr. Louis P. Salley and Dr. Jacques Simoneau.
Other Corporate and Financial Information
On February 27, 2020, a total of 965,000 stock options have been granted to its directors, officers, employees and consultants. Of this number, 895,000 have been granted to its directors and officers and 115,000 to its employees and consultants. These options have an exercise price of $1.44 per share; they will vest after six (6) months and will thereafter be exercisable at any time until February 27, 2030.
Azimut has recently received an amount totalling $865,702 from the exercise of warrants at a price of $0.35 per share ($773,702) and $0.46 per share ($92,000). Four insiders have exercised stock options at a price of $0.66 per share for a total amount of $184,800. No fees are related to these issuances.
The Board of Directors has passed a resolution to amend the stock option plan of the Corporation in accordance with the provisions of Policy 4.4 of the TSX Venture Exchange. Pursuant to said amendment, the Corporation has added a clause allowing the extension of the exercise period of any stock option that expires during a blackout period or within 10 days following the end of such period.
About Azimut Exploration
Azimut is a mineral exploration company whose core business is centred on target generation and partnership development. The Company uses a pioneering approach to big data analytics (the proprietary AZtechMineTM expert system) enhanced by extensive exploration know-how. Azimut maintains rigorous financial discipline and has 63.9 million shares outstanding.
Azimut holds the largest mineral exploration portfolio in Quebec. The Company's competitive edge against exploration risk is founded on systematic regional-scale data analysis and multiple concurrently active projects. This includes two regional strategic alliances with SOQUEM for six (6) gold properties.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Azimut Exploration Inc.
View original content: http://www.newswire.ca/en/releases/archive/February2020/28/c1222.html
Jean-Marc Lulin, President and CEO, Tel.: (450) 646-3015, Fax: (450) 646-3045, firstname.lastname@example.org
BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today reported its financial and operating results for the year ended December 31, 2019.
“The Company closed 2019 on a strong, positive trajectory, and we look at the past year as one of substantial growth and progress in the areas of clinical and corporate development,” said Roberto Bellini, President and Chief Executive Officer of BELLUS Health. “Last year was highlighted by the initiation of our Phase 2 RELIEF trial of BLU-5937 in chronic cough, as well as by our US$79.4 million equity offering and beginning of trading on the Nasdaq exchange. These critical achievements have positioned BELLUS Health to execute on this year’s upcoming milestones and development plans, including the data readout for the RELIEF trial in chronic cough and the initiation of the Phase 2 trial in chronic pruritus, a second indication for BLU-5937.”
PROGRAM AND CORPORATE HIGHLIGHTS
- Ongoing Phase 2 RELIEF trial of BLU-5937 for the treatment of refractory chronic cough, with top-line results anticipated in mid-2020.
In July 2019, the Company enrolled the first patient in the Phase 2 RELIEF trial of BLU-5937 for the treatment of refractory chronic cough. The Company expects to complete patient enrollment by the end of March, with topline results anticipated in mid-2020.
- Completed a clinical Phase 1 drug-drug interaction (“DDI”) trial of BLU-5937 in 28 healthy adult subjects demonstrating no clinically significant interaction with CYP3A4, OATP1B1 and BCRP.
In December 2019, the Company completed a DDI trial, which indicated that the administration of BLU-5937 should not affect the elimination of other drugs that are substrates of these enzymes/transporters. BLU-5937 was found to be safe and generally well tolerated in the trial (200 mg BID dose administered for 10 days). Two subjects out of 28 (7%) reported a mild taste alteration, which occurred only on the first day of dosing.
- Closed a US$79.4 million equity offering and began trading on the Nasdaq.
In September 2019, the Company issued a total of 11,179,451 common shares from treasury at a price of US$7.10 per share for aggregate gross proceeds of C$104.6 million (US$79.4 million). Concurrently with the pricing of its equity offering, BELLUS Health’s common shares began trading on the Nasdaq Global Market (“Nasdaq”) on September 5, 2019.
- Appointed Catherine Bonuccelli, MD as Chief Medical Officer.
In August 2019, the Company hired Dr. Bonuccelli, who brings over 20 years of pharmaceutical experience at GSK and Astra Zeneca with significant expertise in clinical development of respiratory products.
- Obtained clearance of U.S. IND for the BLU-5937 Phase 2 trial in chronic pruritus; Phase 2 trial to commence in Q2 2020.
On February 20, 2020, the U.S. Food and Drug Administration ("FDA") accepted the Company's Investigational New Drug ("IND") application for BLU-5937 for the treatment of chronic pruritus associated with atopic dermatitis (“AD”), also known as eczema. The clinical Phase 2 trial is expected to be initiated in Q2 2020. In July 2019, the Company announced that it was expanding its BLU-5937 P2X3 antagonist platform to include chronic pruritus and in September 2019, presented preclinical data on BLU-5937 in pruritus at the European Society for Dermatological Research Conference.
- Held a Key Opinion Leader (“KOL”) meeting to discuss the state of chronic cough treatment.
In July 2019, the Company held a KOL event, which was led by Dr. Jacky Smith, Professor at the University of Manchester, United Kingdom, to discuss chronic cough and BLU-5937. A replay of the event is available on the Events & Presentations page of the Company’s website.
- Cash Position: As of December 31, 2019, the Company had available cash, cash equivalents and short-term investments totalling C$116,884,000 (US$89,980,000), compared to C$48,906,000 (US$35,863,000) as at December 31, 2018.
- Net Loss: For the year ended December 31, 2019, net loss amounted to C$34,466,000 (C$0.73 per share), compared to C$9,084,000 (C$0.27 per share) for the previous year.
- Research and Development Expenses: Research and development expenses, net of research tax credits, amounted to C$25,409,000 for the year ended December 31, 2019, compared to C$6,532,000 for the previous year. The increase is primarily attributable to higher expenses incurred in relation to the development of BLU-5937, mainly for the manufacturing of the active pharmaceutical ingredient for upcoming studies and activities in relation to the Phase 2 trial in refractory chronic cough, for which the first patient was enrolled in July 2019.
- General and Administrative Expenses: General and administrative expenses amounted to C$8,726,000 for the year ended December 31, 2019, compared to C$3,409,000 for the previous year. The increase is mainly a result of expenses incurred in relation to the Nasdaq listing in September 2019 as well as a higher stock-based compensation expense due to the Company’s deferred share unit plan and its stock option plan.
- Net Finance (Costs) Income: Net finance costs amounted to C$366,000 for the year ended December 31, 2019, compared to net finance income of C$741,000 for the previous year. The increase in net finance costs is primarily attributable to foreign exchange loss that arose from the translation of the Company’s net monetary assets denominated in US dollars, partially offset by higher interest income due to increased cash, cash equivalents and short-term investments position following the 2019 equity offering.
The Company’s full audited consolidated financial statements and accompanying management’s discussion and analysis for the year ended December 31, 2019 will be available shortly on SEDAR at www.sedar.com and on EDGAR at www.sec.gov/edgar.
About BELLUS Health (www.bellushealth.com)
BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. The Company's product candidate, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus.
Chronic cough, the lead indication for BLU-5937, is a cough lasting more than eight weeks and is associated with significant adverse physical, social and psychosocial effects on health and quality of life. It is estimated that approximately 26 million adults in the United States suffer from chronic cough with more than 2.6 million having refractory chronic cough lasting for more than a year. There is no specific therapy approved for refractory chronic cough and treatment options are limited.
Chronic pruritus, commonly known as chronic itch, is an irritating sensation that leads to scratching, and persists for longer than six weeks, which can be debilitating and has a significant impact on quality-of-life. It is a hallmark of many conditions, including AD. It is estimated that chronic pruritus associated with AD affects more than 16.9 million adults in the United States.
BLU-5937, a highly selective P2X3 antagonist - ( >1500 fold) for human P2X3 receptors, which are implicated in chronic cough, versus P2X2/3 receptors, which play a major role in taste - has the potential to be an important treatment option for chronic cough, chronic pruritus and other hypersensitization-related disorders.
The P2X3 receptor in the cough reflex pathway is a rational target for treating chronic cough, and it has been validated in multiple clinical trials with different P2X3 antagonists. With a low-selectivity P2X3 antagonist therapy for chronic cough, an adverse effect on taste perception is a well-known and widely-documented tolerability issue. The Company believes that its highly selective P2X3 antagonist can also reduce coughing in patients with chronic cough, while maintaining taste function, by not inhibiting P2X2/3 receptors. This hypothesis has been validated in a recent clinical trial with a more selective antagonist of P2X3; however, BLU-5937 is the most selective of the P2X3 antagonists currently being studied.
In addition to chronic cough and chronic pruritus, BLU-5937 may also have broad applicability across other afferent hypersensitization-related disorders, potentially enabling the Company to build a pipeline of therapies using its P2X3 platform. BELLUS Health is exploring how P2X3 activation can contribute to irritation and pain, and whether inhibition of P2X3 receptors can help treat these afferent hypersensitization-related disorders.
Certain statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, may constitute "forward-looking statements" within the meaning of Canadian securities legislation and regulations and other applicable securities laws. Such statements, based as they are on the current expectations of management, inherently involve numerous important risks, uncertainties and assumptions, known and unknown, many of which are beyond BELLUS Health's control. Such statements include, but are not limited to, BELLUS Health’s expectations related to its preclinical and clinical studies, including the timing and results for the BLU-5937 Phase 2 RELIEF trial and its chronic pruritus program. Risk factors that may affect BELLUS Health’s future results include but are not limited to: the ability to expand and develop its project pipeline, the ability to obtain financing, the impact of general economic conditions, general conditions in the pharmaceutical industry, changes in the regulatory environment in the jurisdictions in which BELLUS Health does business, stock market volatility, heavy dependence on licensed intellectual property, fluctuations in costs, changes to the competitive environment due to consolidation, achievement of forecasted burn rate, potential payments/outcomes in relation to indemnity agreements and contingent value rights, achievement of forecasted preclinical and clinical study milestones, reliance on third parties to conduct preclinical studies and clinical trials for BLU-5937 and that actual results may vary once the final and quality-controlled verification of data and analyses has been completed. In addition, the length of BELLUS Health's product candidate's development process, its market size and commercial value, as well as the sharing of proceeds between BELLUS Health and its potential partners from potential future revenues, if any, are dependent upon a number of factors. Moreover, its growth and future prospects are mainly dependent on the successful development, regulatory approval and commercialization of its product candidate BLU-5937. Consequently, actual future results and events may differ materially from the anticipated results and events expressed in the forward-looking statements. BELLUS Health believes that expectations represented by forward-looking statements are reasonable, yet there can be no assurance that such expectations will prove to be correct. The reader should not place undue reliance, if any, on any forward-looking statements included in this news release. These forward-looking statements speak only as of the date made, and BELLUS Health is under no obligation and disavows any intention to update publicly or revise such statements as a result of any new information, future event, circumstances or otherwise, unless required by applicable legislation or regulation. Please see BELLUS Health's public filings with the Canadian securities regulatory authorities, including the Annual Information Form, for further risk factors that might affect BELLUS Health and its business.
SUMMARY OF FINANCIAL RESULTS
MONTREAL, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce a new strategic alliance with SOQUEM in the Grenville Province and an agreement to regain 100% interest in the Casault and Jouvex gold projects, previously in joint venture with SOQUEM. In exchange, Midland relinquishes 50% interest in its seven (7) properties grouped under the Gatineau Zinc project located in the Grenville Province, south of the town of Maniwaki, Quebec.
Strategic alliance in the Grenville
SOQUEM and Midland agree to enter into a joint venture agreement and a strategic alliance in the Grenville. SOQUEM and Midland will jointly implement a targeting approach to identify and assess the mineral resource potential and to acquire mining rights covering the best targets for base metals.
Projects acquired under the target generation program will be declared “Designated Projects” once the mining rights have been acquired. Each Designated Project will be the object of a distinct joint venture agreement, the terms of which will be similar to the joint venture agreements to be signed relating to the active properties.
A management committee composed of four members, two nominated by each party, will manage activities conducted under the target generation program for the duration of the agreement. The parties are not subject to budgetary obligations under the target generation program. The budget will be defined by the management committee. The target generation program will last for a period of 2 years, unless it is extended by mutual written consent of both parties.
SOQUEM will be project manager under the target generation program and for all joint ventures formed on Designated Projects; Midland may assign up to 30% of personnel.
Midland regains 100% interest in the Casault and Jouvex projects (the “Properties”)
Under the agreement, SOQUEM transfers to Midland its 50% interest in the Properties in exchange for:
- A 1% NSR royalty; Midland may, at any time, buy back the royalty, in all or in part, by making a cash payment of $1,000,000 per tranche of 0.5% NSR; and
- 50% undivided interest in a joint venture relating to seven (7) existing mining properties located in the La Vallée-de-la-Gatineau regional county municipality (“MRC”), wholly owned by Midland (the “Existing Properties”).
The Casault project is located approximately 140 kilometres north of the town of La Sarre in Abitibi, Quebec. The property consists of 316 claims covering a surface area of approximately 174 square kilometres, about 40 kilometres east of the Detour Lake gold deposit. Gold is associated with quartz veining in altered mafic volcanic rocks with disseminated pyrite mineralization. Drill hole CAS-12-07 intersected 10.4 g/t Au over 1.45 m from 176.60 to 178.05 m (see press release dated April 26 2012) and drill hole CAS-15-53 intersected 6.9 g/t Au over 1.1 m in the same area between 395.00 and 396.10 m (see press release dated October 22 2015). A gold-bearing porphyry intrusion (QFP) was also recognized on the property in 2017 (Vortex zone). Drill hole CAS-17-96 yielded a grade of 1.38 g/t Au over 26.5 m in this zone between 155.80 and 182.00 m, including 7.9 g/t Au over 2.2 m from 179.80 to 182.00 m (see press release dated January 18 2018). The property is well positioned less than 10 km of the Tabasco / Fenelon and Area 51 gold discoveries of Wallbridge. A new drilling program is currently in preparation.
The Jouvex property is located approximately 50 kilometres west of the town of Matagami in Abitibi, Quebec. The property consists of 248 claims covering a surface area of approximately 138 square kilometres. The property covers a 10-kilometre-long segment of the Casa Berardi fault zone that exhibits a regional flexure. Numerous gold-bearing drill intercepts are reported in sedimentary rocks and iron formations, in a setting similar to the Casa Berardi mine located 65 kilometres further west.
The Existing Properties
The Bouchette property is located east and southeast of the municipality of Messines, and 12 kilometres south of the town of Maniwaki in the La Vallée-de-la-Gatineau MRC. It consists of 31 map-designated cells totalling 1,843.48 ha. The property hosts the Bouchette prospect. Hole BO-94-03, drilled in 1994 (GM53111) had returned 3.3 % Zn over 9.6 m between 9.5 and 19.1 m.
The Leitch property is located 7 kilometres northeast of the municipality of Gracefield in the La Vallée-de-la-Gatineau MRC. It consists of 40 map-designated cells covering a surface area of 2,384.84 ha. The property encompasses the Leitch zinc prospect and the former Lafontaine zinc mine. Two channels completed on the Leitch surface showing had returned 24.1 % Zn over 3.0 metres and 32.4 % Zn over 2.0 metres (unpublished data). Another channel cut on the Lafontaine showing had returned 21.0 % Zn over 2.0 metres (unpublished data).
The Aumond property is located 3 kilometres east of the municipality of Aumond in the La Vallée-de-la-Gatineau MRC. It consists of 37 map-designated cells totalling 2,191.61 ha. An historical channel had yielded 6.08 % Zn over 0.8 metre (GM56261).
The Chute-Rouge property is located 7 kilometres west of the town of Grand-Remous in the La Vallée-de-la-Gatineau MRC. It consists of 50 map-designated cells covering a surface area of 2,955.45 ha.
The Blue Sea property is located 1.5 kilometres southeast of the municipality of Blue Sea in the La Vallée-de-la-Gatineau MRC. It consists of 3 map-designated cells totalling 169.53 ha.
The Bois Franc property is located 2.5 kilometres north of the town of Maniwaki and borders, to the east, the Egan-Sud and Bois-Franc municipalities in the La Vallée-de-la-Gatineau MRC. It consists of 71 claims covering a surface area of 4,127.67 ha.
The Zone A property is located 1.5 kilometres southeast of the municipality of Blue Sea in the La Vallée-de-la-Gatineau MRC. It consists of 27 map-designated cells covering a surface area of 1,610.04 ha.
Mineralization occurring at the Detour Lake mine and on the Fenelon project/Tabasco/Area 51 is not necessarily representative of mineralization that may be found on the Casault property.
Note that the true thickness of reported drill and channel intervals cannot be determined with the information currently available.
SOQUEM, a subsidiary of Investissement Québec, is dedicated to promoting the exploration, discovery and development of mining properties in Quebec. SOQUEM also contributes to maintaining strong local economies. A proud partner and ambassador for the development of Quebec’s mineral wealth, SOQUEM relies on innovation, research and strategic minerals to be well-positioned for the future
Midland targets the excellent mineral potential of Quebec to make the discovery of new world-class deposits of gold, platinum group elements and base metals. Midland is proud to count on reputable partners such as SOQUEM INC., BHP Billiton Canada Inc., Agnico Eagle Mines Limited, O3 Mining, Nunavik Mineral Exploration Fund, and Abcourt Mines Inc. Midland prefers to work in partnership and intends to quickly conclude additional agreements in regard to newly acquired properties. Management is currently reviewing other opportunities and projects to build up the Company portfolio and generate shareholder value.
This press release was prepared by Mario Masson. P.Geo., VP Exploration for Midland and Qualified Person as defined by NI 43-101, who also approved the technical content of this press release.
For further information, please consult Midland’s website or contact:
Gino Roger, President and Chief Executive Officer
Tel.: 450 420-5977
Fax: 450 420-5978
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release may contain forward-looking statements that are subject to known and unknown risks and uncertainties that could cause actual results to vary materially from targeted results. Such risks and uncertainties include those described in Midland’s periodic reports including the annual report or in the filings made by Midland from time to time with securities regulatory authorities.
Photos accompanying this announcement are available at:
Toronto, Ontario--(Newsfile Corp. - February 27, 2020) - GoldSpot Discoveries Corp. (TSXV: SPOT) ("GoldSpot" or the "Company") commends Yamana Gold Inc. ("Yamana") on its strong reported fourth quarter and full year 2019 results (see Yamana's press release of February 13, 2020). Of particular interest for GoldSpot is Yamana's mention of the use of machine learning technology to improve exploration targeting and also contribute to the meaningful increases in mineral resource inventory at its El Peñón mine.
Yamana reports that El Peñón's mineral reserves both replaced 2019 depletion and further increased such mineral reserves by 15% and 21% for gold and silver, respectively, as the result of positive infill drilling and mine design optimization. Furthermore, measured and indicated mineral resources increased by 66% while silver increased by 70% compared to the prior year, due to the positive exploration results from numerous secondary vein structures in the east mine.
El Peñón has a long history of exploration and drill data, and Yamana is currently exploring targets defined in part by GoldSpot's artificial intelligence ("AI") algorithms to best predict areas for drilling for mineralization. Targets, including targets generated through AI analyses, are defined by favorable lithological package (rhyolites), high white mica crystallinity and anomalous geochemical and geophysical signatures, and will be further investigated through drilling in 2020.
To date, GoldSpot has been able to supplement and reinforce conventional targeting outlined by Yamana's team, and further generate new zones of interest that Yamana has earmarked for continued exploration in the coming 2020 exploration campaign. GoldSpot is grateful to have been given the opportunity to work alongside Henry Marsden and his high-quality exploration team, push the limits of data, reinvigorate exploration efforts at El Peñón and showcase the power of modern exploration techniques by demonstrating what they can bring to a world-class project with a world-class data set and team of experts.
"The past year has seen some very encouraging preliminary results that reinforces the value that AI and machine learning bring to the exploration workflow. We are looking forward to the results of the 2020 drilling campaign, which will further highlight the importance of new technologies in the exploration process." Denis Laviolette, President and CEO of GoldSpot Discoveries Corp.
"The collaborative AI process undertaken with GoldSpot has allowed Yamana's exploration team to leverage many years of multidisciplinary exploration data and is playing a significant role in the current exploration targeting process at El Peñón. We are pleased with the progress that our partnership with GoldSpot has yielded so far and look forward to continued success." Henry Marsden, Senior Vice President, Exploration, at Yamana.
The technical information in this press release has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43-101 (Standards of Disclosure for Mineral Projects) and reviewed and approved by Lindsay Hall, professional geoscientist (APGO # 0891), a Qualified Person as defined in NI 43-101.
About GoldSpot Discoveries
GoldSpot Discoveries Corp. (TSXV: SPOT) is a Canadian technology company transforming a traditional industry using artificial intelligence and machine learning. As the first publicly-traded AI company in mineral exploration, GoldSpot Discoveries uses machine learning as a powerful extension of geological brainpower to unlock deep value in data. In addition to service offerings and strategic investments, GoldSpot has developed a first of its kind AI driven trading platform giving investors a new way to play the mining space.
For further information please contact:
Denis Laviolette, President, CEO and Director
GoldSpot Discoveries Corp.
Neither the TSX Venture Exchange ("TSXV") nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52856
OTTAWA, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV-CGP) (F-GWN) (B-GWN) (OTC-CTNXF) is pleased to announce exploration results to date at its Espejo and Rio Magdalena projects located within the Cornerstone Ecuador S.A. (“CESA”) - ENAMI EP strategic exploration alliance (the “ENAMI-CESA SEA”) in Northern Ecuador.
Figures related to this news release can be seen in PDF format by accessing the version of this release on the Company’s website (www.cornerstoneresources.com) or by clicking on the link below:
- Prospecting work and initial geological mapping completed
- Heliborne magnetic and radiometric survey (1560 lineKm) defines anomalies related to magnetic bodies, altered zones and structures
- 3410 samples collected to date
- Spectrometry work (Terraspec) defines alteration patterns typical of porphyry systems
- Three sizeable (more than 1 km²), high priority porphyry Cu-Mo (Au) targets defined
- Epithermal style Au-Ag mineralization locally associated to porphyries
- Several lower priority targets to be followed up
- Future work to focus on target areas: Detailed ground surveys and 3D magnetic modeling (underway), ground geophysics being planned, drilling targets to be defined
- Minimal work commitment over the first 4 years attained in less than 3 years
- Prospecting work and initial geological mapping completed
- Heliborne magnetic and radiometric survey (915 lineKm) defines anomalies related to magnetic bodies, structures, altered and mineralized zones
- 3801 samples collected to date
- Spectrometry work (Terraspec) defines alteration patterns typical of porphyry systems
- Two high priority, sizeable (more than 1 km²), porphyry Cu-Au (Mo) targets outlined
- Other lower priority targets to be followed up
- Future work to focus on target areas: Detailed surveys ongoing, ground geophysics being planned, drilling targets to be defined
- Minimal work commitment over the first 4 years attained in less than 3 years
In commenting on the results, Cornerstone’s CEO, Brooke Macdonald, said:
“We and our partner, Ecuador’s state mining company ENAMI, are pleased to announce the initial results on two of the 3 project blocks within the ENAMI-CESA SEA. The size and intensity of the anomalies and the outcropping mineralization are similar to those we identified at Cascabel back in 2012-2013 when Cascabel was at a similar stage of development. Cascabel totals around 5,000 hectares; the 3 concession blocks in the ENAMI-CESA SEA (Espejo, Rio Magdalena and Playa Rica) total around 42,000 hectares, and none of the targets on the 9 concessions within the 3 blocks have ever been drilled.
"The Espejo, Rio Magdalena, and Playa Rica blocks were identified and ranked by Cornerstone in 2015-2016 as highly prospective after an exhaustive analysis of public and private information available at the time, reserved by CESA after the opening of the cadastral map and then transferred to ENAMI for inclusion in the SEA. We believe we have secured some of the best areas in this largely unexplored region of north west Ecuador.
"Exploration targets are of high quality, showing strong coincidence between highly anomalous copper-gold-moly geochem results, porphyry-type magnetic response and prospective geological environment. Subject to permitting and securing a suitable funding partner, drilling of these targets is planned during the second half of 2020.
"We would like to thank ENAMI’s management and technical staff for their assistance and support during these past 3 years, and look forward to making one or more major discoveries with them on these projects.”
Cornerstone Ecuador SA (“CESA”), a wholly owned subsidiary of Cornerstone Capital Resources Inc. (TSXV: CGP) has outlined several high priority porphyry Cu-Mo (Au) and Cu-Au (Mo) exploration target areas on its Espejo and Rio Magdalena projects located, respectively, in Carchi and Imbabura provinces, in northern Ecuador. See location map on Figure 1. These properties are part of the Ecuadorian State mining company, ENAMI EP – CESA Strategic Exploration Alliance (the “ENAMI-CESA SEA”). The properties, totaling 9 concessions in three blocks, Espejo, Playa Rica and Rio Magdalena, were selected by CESA through a thorough compilation of public and private data and a regional prospecting program during the period 2015 and 2016. Concessions were applied for by and granted to ENAMI on behalf of the SEA partners.
Following various community & social responsibility outreach processes carried out by CESA and ENAMI with regional and local authorities and communities, systematic exploration surveys were implemented starting in Q3 of 2017, including prospecting work, stream sediment sampling (1063 samples), rock sampling (1459 rock samples), ridge and spurs and grid soil sampling (4691 samples).
Spectrometry work was carried out on all rock and soil samples. Alteration patterns typical of porphyry style mineralization were used as vectors to mineralization.
A detailed heliborne magnetic and radiometric survey was carried out at Espejo (1560 lineKm) and Rio Magdalena (965 lineKm). Geophysical data was processed and anomalies defined. 3D magnetic modelling is underway to refine the geological and metallogenic models.
Full data integration, including geology, alteration, geochem results and geophysical data was then performed and anomalous areas defined for follow-up work.
Exploration follow-up results confirmed the presence of several, highly prospective, porphyry Cu-Mo (Au) style mineralization at Espejo and porphyry Cu-Au (Mo) style mineralization at Rio Magdalena. Mineralization is usually hosted by (but not restricted to) high density quartz veinlets stockworks within altered intrusive and sedimentary and/or volcanic host rocks. No drilling has ever been carried out on the two projects. Several lower priority targets still need to be followed up.
Espejo Project (19,462 Has property – 4 concessions):
Anomaly ESP #1 is 1.9km by 1.3km in size, showing strong and coincident Cu-Mo-Au results and high Cu/Zn ratio with both rock and soil samples (Figure 2, Figure 3 and Plate 1). The anomaly is wide open to the NW. Geological mapping and soil sampling indicates that mineralization is preferentially associated to high density B, M and D-type quartz veinlets stockworks within dacitic porphyries and surrounding mylonite, andesitic volcanic and sedimentary host rocks. Higher density veinlets (>50 vn/m) are located in the core of the anomaly. This anomalous zone is located at the contact zone of NE oriented, high and low magnetic bodies.
Anomaly ESP #2 as explored to date has a minimal size of 2.0km by 1.0km (Figure 4, Figure 5 and Plate 2). It hosts partially coincident Cu-Mo-Au rock. Grid soil sampling has begun. Mineralization is associated to B and A quartz veinlets stockworks within porphyry intrusive and sedimentary country rocks. The anomaly is mostly located within a moderate magnetic surrounded to the N, W and S by magnetic bodies.
Anomaly ESP #3 as explored to date has a minimal size of 1.8km by 0.9km (Figure 6, Figure 7 and Plate 3), showing partially coincident Au-Cu-Mo results and moderate to high Cu/Zn ratio with both rock and soil samples. Mineralization found so far is associated to weakly developed quartz stockwork close to NNW structures, within andesitic porphyry. The anomaly is located within a moderate magnetic background surrounded by NE oriented magnetic bodies.
Rio Magdalena project (9.909 Has property – 3 concessions):
Two high priority porphyry Cu-Au (Mo) targets are defined.
Anomaly RM #1 is 1.5 km by 0.8 Km in size and shows coincident Cu-Au (Mo) rock and soil anomaly and high Cu/Zn rock within a low frequency magnetic low (Figure 8, Figure 9 and Plate 4). The anomaly is still open to the north. Mineralization is associated to high density quartz-magnetite veinlets stockwork within diorite porphyries hosted (and partially covered) by altered/mineralized sedimentary rocks. A, B and M-type veinlets density is higher than 100 vn/m in the core of the anomaly.
Anomaly RM #2 has a 1.5km by 1.5km size and shows similarities with anomaly #1 but associated to a high amplitude magnetic high this time: coincident Cu-Au-Mo rock and soil anomaly and high Cu/Zn ratio (Figure 10, Figure 11 and Plate 5). The soil anomaly is still open in several directions. Mineralization is associated to magnetite veinlets stockworks within diorite porphyries hosted (and partially covered) by altered sedimentary country rocks.
About the ENAMI EP - Cornerstone Strategic Exploration Alliance (SEA)
On June 14, 2016, Cornerstone announced that its Ecuadorean subsidiary, Cornerstone Ecuador S.A. (“CESA”), had signed a Spanish language Agreement, or Acuerdo de Colaboración e Inversión para el Desarrollo Conjunto de Proyectos de Exploración Minera (the “Agreement”) with Ecuador’s State Mining Company, Empresa Nacional Minera Empresa Pública (“ENAMI EP”), replacing a letter of intent announced April 14, 2015, and creating a structure to jointly prospect and explore for mineral deposits in Ecuador (the “ENAMI-CESA Strategic Exploration Alliance” or “ENAMI-CESA SEA”).
On March 6, 2017, Cornerstone announced that ENAMI EP had been granted a number of mineral concessions in Imbabura and Carchi provinces in the same area as the Cascabel (SolGold/Cornerstone) and Llurimagua (Codelco/Enami) concessions, for exploration by the ENAMI-CESA SEA. Nine concession titles totaling around 42,000 hectares were granted in 2017 by the Ministry of Mining (now the Ministry of Energy and Non-Renewable Natural Resources).
For more information about the ENAMI-CESA SEA, please see Cornerstone news release 16-12 dated June 14, 2016 http://www.cornerstoneresources.com/s/NewsReleases.asp?ReportID=752183
Yvan Crepeau, MBA, P.Geo., Cornerstone’s Vice President, Exploration and a qualified person in accordance with National Instrument 43-101, is responsible for supervising the exploration program at the Espejo and Rio Magdalena projects for Cornerstone and has reviewed and approved the information contained in this news release.
Sampling and assaying
CESA uses a fire assay gold technique for Au assays (FAS-111) and a four acid multi element technique (IMS-230) for a suite of 48 elements. FAS-111 involves Au by Fire Assay on a 30-gram aliquot, fusion and atomic absorption spectroscopy (AAS) at trace levels. IMS-20 is considered a near total 4 acid technique using a 20g aliquot followed by multi-element analysis by ICP-AES/MS at ultra-trace levels. This analysis technique is considered suitable for this style of mineralization.
Standards, blanks and duplicates are inserted ~1/25 samples. The values of the standards range from low to high grade and are considered appropriate to monitor performance of values near cut-off and near the mean grade of the deposit. The check sampling results are monitored and performance issues are communicated to the laboratory if necessary.
Sample security was managed through sealed individual samples and sealed bags of multiple samples for secure delivery to the laboratory by permanent staff of the joint-venture. MS Analytical is an internationally accredited laboratory that has all its internal procedures heavily scrutinized in order to maintain their accreditation. MS Analytical is accredited to ISO/IEC 17025 2005 Accredited Methods.
CESA’s sampling techniques and data have been audited multiple times by independent mining consultants during various project assessments. These audits have concluded that the sampling techniques and data management are to industry standards. All historical data has been validated to the best degree possible and migrated into a database.
Rock samples are collected by CESA’s personnel, placed in plastic bags, labeled and sealed, and stored in a secure place until delivery by CESA employees to the LAC y Asociados ISO 9001-2008 certified sample preparation facility in Cuenca, Ecuador.
Rock samples are prepared crushing to 70% passing 2 mm (10 mesh), splitting 250 g and pulverizing to 85% passing 75 microns (200 mesh) (MSA code PRP-910). Prepared samples are then shipped to MS Analytical Services (MSA), an ISO 9001-2008 laboratory in Langley, BC, Canada, where samples are assayed for a multi-element suite (MSA code IMS-136, 15.0 g split, Aqua Regia digestion, ICP-AES/MS finish) and gold by Fire Assay (MSA code FAS-111, 30 g fusion, AAS finish). Over limit results for Cu (>1%) are systematically re-assayed (MSA code ICF-6Cu, 0.2 g, 4-acid digestion, ICP-AES finish). Gold is assayed using a 30 g split, Fire Assay (FA) and AAS finish (MSA code FAS 111). Over limit results for Au (>10 g/t) are systematically re-assayed (MSA code FAS-415, FA, 30g., gravimetric finish).
Soil samples are dried at low temperature, screened to 80 mesh (MSA code PRP-757), a 15 grams portion is then assayed for a multi-elements suite (MSA code IMS-136, Aqua Regia digestion, ICP-AES/MS finish).
Quality assurance / Quality control (QA/QC)
The MSA Analytical Laboratory is a qualified assayer that performs and makes available internal assaying controls. Duplicates, certified blanks and standards are systematically used (1 control sample every 20-25 samples) as part of PLAMIN’s QA/QC program. Rejects, a 100 g pulp for each rock sample, are stored for future use and controls.
Cornerstone Capital Resources Inc. is a mineral exploration company with a diversified portfolio of projects in Ecuador and Chile, including a 22.2% interest in the Cascabel gold-enriched copper porphyry joint venture in north west Ecuador, composed of a 15% direct equity interest in Exploraciones Novomining S.A. (“ENSA), the Ecuadorian company that holds title to the Cascabel concession, financed by joint venture partner and project operator SolGold Plc through to completion of a feasibility study and repayable at Libor plus 2% out of 90% of Cornerstone’s 15% share of earnings or dividends from an operation at Cascabel, plus 8.5% of the shares of SolGold.
Further information is available on Cornerstone’s website: www.cornerstoneresources.com and on Twitter. For investor, corporate or media inquiries, please contact:
Investor Relations: Mario Drolet; Email: Mario@mi3.ca; Tel. (514) 904-1333
Due to anti-spam laws, many shareholders and others who were previously signed up to receive email updates and who are no longer receiving them may need to re-subscribe at http://www.cornerstoneresources.com/s/InformationRequest.asp
This news release may contain ‘Forward-Looking Statements’ that involve risks and uncertainties, such as statements of Cornerstone’s beliefs, plans, objectives, strategies, intentions and expectations. The words “potential,” “anticipate,” “forecast,” “believe,” “estimate,” “intend”, “trends”, “indicate”, “expect,” “may,” “should,” “could”, “project,” “plan,” or the negative or other variations of these words and similar expressions are intended to be among the statements that identify ‘Forward-Looking Statements.’ Although Cornerstone believes that its expectations reflected in these ‘Forward-Looking Statements’ are reasonable, such statements may involve unknown risks, uncertainties and other factors disclosed in our regulatory filings, viewed on the SEDAR website at www.sedar.com. For us, uncertainties arise from the behaviour of financial and metals markets, predicting natural geological phenomena and from numerous other matters of national, regional, and global scale, including those of an environmental, climatic, natural, political, economic, business, competitive, or regulatory nature. These uncertainties may cause our actual future results to be materially different than those expressed in our Forward-Looking Statements. Although Cornerstone believes the facts and information contained in this news release to be as correct and current as possible, Cornerstone does not warrant or make any representation as to the accuracy, validity or completeness of any facts or information contained herein and these statements should not be relied upon as representing its views after the date of this news release. While Cornerstone anticipates that subsequent events may cause its views to change, it expressly disclaims any obligation to update the Forward-Looking Statements contained herein except where outcomes have varied materially from the original statements.
On Behalf of the Board,
President and CEO
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
QUEBEC CITY, Feb. 27, 2020 (GLOBE NEWSWIRE) -- (TSXV: HEO) – H2O Innovation is proud to announce the success of its very first humanitarian aid program, in which two of its employees were sent to Zambia last November to raise awareness and educate communities on water and sanitation. The company, which positions itself as a leader in avant-garde ESG (Environment, Social, Governance) practices and policies, has deployed this audacious humanitarian initiative as part of a global approach integrating socially responsible management practices.
After working jointly with the non-governmental organization CAWST (Centre for Affordable Water and Sanitation Technology), in the development of this innovative program, H2O Innovation invited all of its 665 employees to submit applications to take part in this unique experience. Fifteen employees participated in the selection process and 2 of them were selected by the CAWST team to use their knowledge and expertise during a 2-week humanitarian aid experience in Zambia, within a project of the organization.
CAWST's approach aims to meet global drinking water and sanitation needs by developing the local knowledge and skills of communities in low and middle-income countries, so that they can implement and operate the solutions sustainably. “Our H2O Innovation volunteers contributed significantly. This program is a great opportunity to involve donors more in our work and harness corporate knowledge and skills to address global issues”, said Millie Adam, Vice President of Global Services, CAWST. Derek Pirraglia, Application and Process Engineer at H2O Innovation, and Kenneth Head, Office Manager in Pascagoula, Mississippi, who were selected to take part in the project, have grown from this enriching experience.
By contributing to this humanitarian aid program, H2O Innovation has concomitantly provided the time and expertise of its two employees, as well as $22,000 in donations to the Canadian charity. The partnership between CAWST and H2O Innovation highlights the common values these two entities share.
The company, whose headquarters are located in Quebec City, has pledged over the past years in terms of ESG (Environment, Social, Governance), remaining consistent with its environmental philosophy as well as its expertise and mission, both aiming to treat and recycle wastewater. The idea to offer their employees the chance to be involved in a humanitarian effort has come naturally to the company’s upper management.
In an era where the retention of qualified personnel is an issue, such an initiative definitely contributes to employee engagement. “We have been working on this avant-garde program for a long time and we are delighted with the result. We first created a humanitarian committee within our team to reflect on the most relevant way for H2O to get involved in various social and humanitarian missions. Rather than participating sporadically in several charitable activities, we have developed something unique that meets both our corporate mission, water, our social responsibility and our desire to make a difference in disadvantaged countries. Not only does this motivate the troops, but we feel that we have made a very concrete contribution to a cause that is dear to us”, added Guillaume Clairet, Chief Operating Officer of H2O Innovation. He confirms that several employees express the desire to help others and make a difference, and he is confident that participation will be even more important in the years to come.
About H2O Innovation
H2O Innovation designs and provides state-of-the-art, custom-built and integrated water treatment solutions based on membrane filtration technology for municipal, industrial, energy and natural resources end-users. The Corporation’s activities rely on three pillars which are i) water & wastewater projects, and services; ii) specialty products, including a complete line of specialty chemicals, consumables and specialized products for the water treatment industry; and iii) operation and maintenance services for water and wastewater treatment systems.
CAWST is a Canadian charity and licensed not-for-profit professional engineering consultancy. CAWST teaches people how to access safe drinking water, sanitation and hygiene in their homes, schools and clinics, using simple, affordable technologies. To do so, CAWST transfers knowledge and skills to organizations and individuals in low- and middle-income countries offering workshops, training resources and consulting services. To learn more about CAWST and its impactful work, visit cawst.org.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
+1 403-243-3285 ext. 258
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e60afe7a-4390-499c-8c13-a9423f0221ea
MONTREAL, Feb. 27, 2020
Following the 32.30 g/t Au over 7.1 metres (23.3 feet) result recently announced (see press release dated February 26, 2020), it was imperative for Monarch Gold to secure the claims around the property.
McKenzie Break now consists of 134 mineral claims covering a total area of 51 km2 or 20 square miles (see the latest properties map).
The McKenzie Break property and its gold mineralization are associated with a favourable intrusion along a southeast-trending secondary structure off the Mainville East fault, a possible extension of the Destor Porcupine Fault.
MONTREAL, Feb. 27, 2020 /CNW Telbec/ - MONARCH GOLD CORPORATION ("Monarch" or the "Corporation") (TSX: MQR) (OTCMKTS: MRQRF) (FRANKFURT: MR7) is pleased to report that it has acquired 91 mineral claims surrounding the McKenzie Break property (the "Property") from a group of private companies and prospectors (the "Vendors"). In addition, the Corporation has acquired 33 mineral claims by staking. In all, the McKenzie Break property now consists of 134 mineral claims covering a total area of 5,106.9 ha (51 km2). The newly defined property boundaries cover an area approximately 14 times the size of the original property and encompass virtually all of the favourable intrusion containing the gold mineralization.
"It was important for us to secure these additional claims around McKenzie Break, especially in light of the excellent results obtained since the property was acquired and particularly from the last drilling program," said Jean-Marc Lacoste, President and Chief Executive Officer of Monarch. "The drill results to date indicate that the McKenzie Break property has excellent exploration potential in all directions and at depth."
Here below are two tables that each show the top 10 intercepts from the McKenzie Break drilling programs since Monarch acquired the property in December 2017, and from drilling programs before acquiring the property based on metal factor (grade times length), which show the extent of the high-grade potential on this property.
LONDON, Ontario, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) and Lift & Co. Corp. (“Lift & Co.”) (TSXV:LIFT) (OTCQB:LFCOF) are pleased to announce the release of Indiva’s CannSell branded education module. The CannSell certification program, created by Lift & Co., in exclusive partnership with MADD Canada, is currently utilized in eight Canadian jurisdictions. CannSell also serves as the provincially-mandated training program for all cannabis retail workers in Ontario. These frontline staff members are responsible for educating consumers on the safe use of cannabis where it is sold. The Indiva education experience on the CannSell platform offers an overview of the Company, its product portfolio, and its commitment to quality, innovation and sustainability.
“We are proud to partner with Lift & Co. in educating this important community about Indiva and our products,” Niel Marotta, Indiva’s President and Chief Executive Officer, said. “Many consumers do not know what to purchase prior to entering a store. Budtenders are a great first point of contact for those interested in learning more about cannabis. Their guidance makes cannabis more accessible and helps Canadians make informed decisions. We look forward to staying connected to the budtender community and working in partnership with organizations like Lift & Co. to educate the public about cannabis, cannabis products and responsible use.”
“Through the CannSell platform, Lift & Co. is able to support brands like Indiva to deliver brand education directly to Canadian budtenders who are critical to consumers’ cannabis education and eventual purchase decisions,” Matei Olaru, CEO of Lift & Co., said. “Whether it’s through this platform, lift.co or Cohesion, Lift & Co.’s entire platform connects brands like Indiva to consumers through several key touchpoints.”
Indiva’s branded education module is available now through the CannSell platform. Individuals interested in learning more about the CannSell program can visit learn.cannsell.ca.
Indiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, oils, and edible products and provides production, manufacturing and refinement services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt, Gems™, and other Powered by INDIVA™ products through license agreements, partnerships and joint ventures. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.
Vice President of Communications
ABOUT LIFT & CO.
Lift & Co. (TSXV:LIFT)(OTCQB:LFCOF) is a publicly traded technology company modernizing the cannabis industry.
Director of Communications, Lift & Co.
DISCLAIMER AND READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the use of proceeds of the Offering, the expectations of management regarding the use of proceeds of the Offering, TSX Venture Exchange approval of the Offering. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Risks that could change or prevent these statements from coming to fruition include either company may not conclude the Offering on terms favourable to either company or at all; the TSX Venture Exchange may not provide final approval of the Offering; and proceeds of the Offering may not be used as stated in this news release. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
Vancouver, British Columbia and Johannesburg, South Africa--(Newsfile Corp. - February 27, 2020) - Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: NPLG) ("Platinum Group" or the "Company") and Impala Platinum Holdings Ltd. (JSE-IMP) ("Implats") announce that the shareholders of Waterberg JV Resources Proprietary Limited ("Waterberg JV Co.") have agreed to amend the terms of the Implats Purchase and Development Option (defined below), which was due to be exercised on April 17, 2020 following the Waterberg JV Co.'s approval of the 2019 Definitive Feasibility Study ("DFS") on December 5, 2019.
In consideration for this amendment, Implats has agreed to fund 100% of a new implementation budget and work programme effective February 1, 2020. The programme, which has been approved by Waterberg JV Co., will be aimed at increasing confidence in specific areas of the DFS while awaiting the expected grant of a Mining Right and Environmental Authorization and is estimated to cost approximately US$4 million. This amount will be offset against Implats' future development funding commitment should it elect to exercise the Purchase and Development Option.
The end date of Implats' Purchase and Development Option will be amended from the original date of April 17, 2020 to 90 calendar days following receipt of an executed Mining Right for the project. All other terms of the Purchase and Development Option remain unchanged.
The work program will include geotechnical drilling along the planned decline positions as set out in the DFS, as well as detailed review of critical areas that could affect the implementation schedule and budget to mitigate execution risks. The sustainability of water supply and a suitable housing strategy will also be progressed further. The Waterberg JV Co. technical committee and Board have approved the work program that includes the initial work for early 2020 outlined in the DFS. Platinum Group will continue to be the Manager of the project, as directed by the technical committee of Waterberg JV Co., and Implats will direct the new work program.
The Mining Right application for the Waterberg project is well advanced.
Further detail on the Purchase and Development Option
On November 6, 2017, Implats purchased 15% of the Waterberg Project for US$30 million. Implats was also granted an option (the "Purchase and Development Option") to increase its stake to 50.01% through additional share purchases from Japan Oil, Gas and Metals National Corporation ("JOGMEC") for an amount of US$34.8 million and earn-in arrangements for US$130 million paid to Waterberg JV Co. to fund development work on the Waterberg Project, as well as a right of first refusal to smelt and refine Waterberg concentrate. A DFS Technical Report, effective September 4, 2019, was approved by Waterberg JV Co. shareholders on December 5, 2019. Before the amendment announced today, Implats had until April 17, 2020 to elect whether or not to exercise the Purchase and Development Option. The amendment announced today allows for the additional project de-risk work to be funded by Impala at 100% with Implats' decision whether to exercise the full Purchase and Development Option to be made within 90 calendar days from the date on which the full Mining Right is executed by the Department of Mineral Resources and Energy.
The work program to be funded by Impala will be a credit to Implats' required US$130 million funding commitment should Implats elect to exercise its Purchase and Development Option. If Impala does not elect to exercise the Purchase and Development Option, funding provided by Implats will not be a credit to Implats, and instead will be an out of pocket expense to Implats. Impala will provide a 90-day notice to Waterberg JV Co. if it elects to not continue with 100% project funding. The proposed program and agreement outlined above will be subject to final documentation and amendments of the formal Purchase and Development Option, the Call Option and other agreements which are expected to be completed promptly.
About Platinum Group Metals Ltd. and Waterberg Project
Platinum Group Metals Ltd. is the operator of the Waterberg Project, a bulk underground palladium and platinum deposit located in South Africa. The Waterberg Project was discovered by Platinum Group and is being jointly developed with Implats, JOGMEC, Mnombo Wethu Consultants (Pty) Ltd. and Hanwa Co. Ltd.
On behalf of the Board of
Platinum Group Metals Ltd.
R. Michael Jones
President and CEO
For further information contact:
R. Michael Jones, President
or Kris Begic, VP, Corporate Development
Platinum Group Metals Ltd., Vancouver
Tel: (604) 899-5450 / Toll Free: (866) 899-5450
The Toronto Stock Exchange and the NYSE American have not reviewed and do not accept responsibility for the accuracy or adequacy of this news release, which has been prepared by management.
This press release contains forward-looking information within the meaning of Canadian securities laws and forward-looking statements within the meaning of U.S. securities laws (collectively "forward-looking statements"). Forward-looking statements are typically identified by words such as: believe, expect, anticipate, intend, estimate, plans, postulate and similar expressions, or are those, which, by their nature, refer to future events. All statements that are not statements of historical fact are forward-looking statements. Forward-looking statements in this press release include, without limitation, statements regarding the planned amendment to the Purchase and Development Option, Call Option and other agreements as discussed herein, potential exercise by Implats of the Purchase and Development Option, financing and mine development at the Waterberg Project and grant of the mine right application. Although the Company believes any forward-looking statements in this press release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct.
The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance and that actual results may differ materially from those in forward-looking statements as a result of various factors, including the Company's inability to generate sufficient cash flow or raise sufficient additional capital to make payment on its indebtedness, and to comply with the terms of such indebtedness; additional financing requirements; the 2019 Sprott Facility is, and any new indebtedness may be, secured and the Company has pledged its shares of Platinum Group Metals (RSA) Proprietary Limited ("PTM RSA"), and PTM RSA has pledged its shares of Waterberg JV Co. to Sprott, under the 2019 Sprott Facility, which potentially could result in the loss of the Company's interest in PTM RSA and the Waterberg Project in the event of a default under the 2019 Sprott Facility or any new secured indebtedness; the Company's history of losses and negative cash flow; the Company's ability to continue as a going concern; the Company's properties may not be brought into a state of commercial production; uncertainty of estimated production, development plans and cost estimates for the Waterberg Project; discrepancies between actual and estimated mineral reserves and mineral resources, between actual and estimated development and operating costs, between actual and estimated metallurgical recoveries and between estimated and actual production; fluctuations in the relative values of the U.S. Dollar, the Rand and the Canadian Dollar; volatility in metals prices; Implats may not exercise the Purchase and Development Option; the Company may become subject to the U.S. Investment Company Act; the failure of the Company or the other shareholders to fund their pro rata share of funding obligations for the Waterberg Project; any disputes or disagreements with the other shareholders of Waterberg JV Co. or Mnombo Wethu Consultants (Pty) Ltd.; the ability of the Company to retain its key management employees and skilled and experienced personnel; conflicts of interest; litigation or other administrative proceedings brought against the Company; actual or alleged breaches of governance processes or instances of fraud, bribery or corruption; exploration, development and mining risks and the inherently dangerous nature of the mining industry, and the risk of inadequate insurance or inability to obtain insurance to cover these risks and other risks and uncertainties; property and mineral title risks including defective title to mineral claims or property; changes in national and local government legislation, taxation, controls, regulations and political or economic developments in Canada and South Africa; equipment shortages and the ability of the Company to acquire necessary access rights and infrastructure for its mineral properties; environmental regulations and the ability to obtain and maintain necessary permits, including environmental authorizations and water use licences; extreme competition in the mineral exploration industry; delays in obtaining, or a failure to obtain, permits necessary for current or future operations or failures to comply with the terms of such permits; risks of doing business in South Africa, including but not limited to, labour, economic and political instability and potential changes to and failures to comply with legislation; the Company's common shares may be delisted from the NYSE American or the TSX if it cannot maintain compliance with the applicable listing requirements; and other risk factors described in the Company's most recent Form 20-F annual report, annual information form and other filings with the U.S Securities and Exchange Commission ("SEC") and Canadian securities regulators, which may be viewed at www.sec.gov and www.sedar.com, respectively. Proposed changes in the mineral law in South Africa if implemented as proposed would have a material adverse effect on the Company's business and potential interest in projects. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise.
Estimates of mineralization and other technical information included herein have been prepared in accordance with NI 43-101. The definitions of proven and probable reserves used in NI 43-101 differ from the definitions in SEC Industry Guide 7. Under SEC Industry Guide 7 standards, mineralization may not be classified as a "reserve" unless the mineralization can be economically and legally extracted or produced at the time the "reserve" determination is made. As a result, the reserves reported by the Company in accordance with NI 43-101 may not qualify as "reserves" under SEC Industry Guide 7. In addition, the terms "mineral resource", "measured mineral resource", "indicated mineral resource" and "inferred mineral resource" are defined in and required to be disclosed by NI 43-101; however, these terms are not defined terms under SEC Industry Guide 7 and historically have not been permitted to be used in reports and registration statements filed with the SEC pursuant to SEC Industry Guide 7. Mineral resources that are not mineral reserves do not have demonstrated economic viability. Investors are cautioned not to assume that any part or all of the mineral deposits in these categories will ever be converted into reserves. In particular, "inferred mineral resources" have a great amount of uncertainty as to their existence and great uncertainty as to their economic and legal feasibility. It cannot be assumed that all or any part of an "inferred mineral resource" will ever be upgraded to a higher category. Disclosure of "contained ounces" in a resource is permitted disclosure under NI 43-101; however, SEC Industry Guide 7 normally only permits issuers to report mineralization that does not constitute "reserves" by SEC Industry Guide 7 standards as in-place tonnage and grade without reference to unit measures. Accordingly, descriptions of the Company's mineral deposits in this press release may not be comparable to similar information made public by U.S. companies subject to the reporting and disclosure requirements of SEC Industry Guide 7.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52840